Examination of the bidirectional relationship between hearing loss and Alzheimer Disease pathology
听力损失与阿尔茨海默病病理学之间双向关系的检查
基本信息
- 批准号:10356939
- 负责人:
- 金额:$ 24.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:APP-PS1AccelerationAdultAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloid beta-ProteinAnimal ModelApolipoprotein EAuditoryAuditory Brainstem ResponsesAuditory ThresholdAuditory systemBehavioralBrainCardiovascular DiseasesCell CycleCentral Auditory DiseasesCharacteristicsClinicalCochlear ImplantsDataDementiaDepositionDevelopmentDichotic Listening TestsDiseaseEarly DiagnosisEarly InterventionEtiologyExposure toFutureGenesGenetic Predisposition to DiseaseGenotypeHearingHearing AidsHearing problemHigh PrevalenceHippocampus (Brain)ImageImpairmentIndividualInterventionLarge T AntigenLearningLinkMeasuresModelingMolecularMusMutationNatureNerve DegenerationNeurofibrillary TanglesNoiseNoise-Induced Hearing LossPathologyPathway interactionsPeripheralPhenotypePopulationPositron-Emission TomographyPresbycusisPrevalenceProcessPublic HealthQuality of lifeResearchResearch PersonnelResearch ProposalsRiskRisk FactorsRodentSpecimenTestingTimeTrainingWorkabeta depositionaging populationauditory processingaural rehabilitationbasebehavior testcognitive changedrug developmenteffective therapyepidemiology studyfamilial Alzheimer diseasefluorodeoxyglucose positron emission tomographyhearing impairmenthuman old age (65+)human subjectimprovedmorris water mazemouse modelneurodegenerative phenotypenew therapeutic targetnoise exposurenovelotoacoustic emissionresponsesimian virusspeech in noisesuccessful interventiontau Proteinstau-1treatment strategy
项目摘要
ABSTRACT
Recent epidemiological studies have revealed an association between aging-related hearing loss
(ARHL) and Alzheimer Disease (AD). Both of these disorders deprive individuals of their quality
of life and both are rapidly rising in prevalence, given the aging of our population. Therefore, it is
critical that we understand how AD and ARHL are related and whether this relationship can be
used as leverage to better understand and treat both disorders. One key question is whether
ARHL and AD are linked because of common risk factors or whether there is a causal relationship
between the two (i.e., does ARHL exacerbate AD pathology?). This question cannot be answered
effectively in human subjects because of the inability to independently manipulate hearing loss.
Therefore, in the current study, we employ two animal models of AD (a model of sporadic and a
model of familial AD) and ask whether manipulation of the peripheral auditory system alters AD
pathology. To do this, we employ a novel model of sporadic AD that is based on cell-cycle
dysregulation – a phenomenon that is commonly observed in brain specimens from AD patients.
These AD model mice therefore do not carry a specific mutation in a gene that directly processes
amyloid beta or tau. Nevertheless, they have been shown to display characteristic plaques and
tangles, similar to what is seen in the AD brain, and neurodegeneration, which is not seen in most
other mouse models of sporadic AD. The model of familial AD that will be used is the APP/PS1
mouse because it has been shown to display central auditory dysfunction and has a time course
of pathology that matches with our sporadic AD model. In Aim 1, we will test both peripheral and
central auditory function in these mice and hypothesize that, like AD patients, they will have more
impairment in central, compared to peripheral, auditory function. In Aim 2, we will induce hearing
loss and examine for exacerbation of AD pathology and induction of a progressive
neurodegenerative phenotype using a combination of serial FDG PET imaging and behavioral
analyses. We hypothesize that hearing loss will worsen AD pathology and exploratory analyses
will be done to determine if changes are more severe in central auditory compared to non-auditory
regions. Successful completion of this work will, for the first time, determine the nature of the
association between hearing loss and AD pathology. If a causal association is found, future work
will determine the molecular mechanisms of this association and whether mitigation of ARHL also
diminishes AD pathology. Given the advancing pace of successful interventions for ARHL (aural
rehabilitation, “smart” hearing aids, cochlear implants, etc.), this research could lay the
groundwork for early intervention for ARHL to diminish the burden of dementia.
抽象的
最近的流行病学研究揭示了与衰老相关的听力损失之间的关联
(ARHL)和阿尔茨海默病(AD)这两种疾病都会剥夺个体的素质。
鉴于我们人口的老龄化,两者的患病率都在迅速上升。
至关重要的是我们了解 AD 和 ARHL 之间的关系以及这种关系是否可以
一个关键问题是是否可以作为更好地理解和治疗这两种疾病的杠杆。
ARHL 和 AD 因共同危险因素或是否存在因果关系而存在关联
两者之间(即 ARHL 是否会使 AD 病理恶化?这个问题无法回答)。
由于无法独立控制听力损失,因此在人类受试者中有效。
因此,在当前的研究中,我们采用了两种 AD 动物模型(散发性模型和
家族性 AD 模型)并询问外周听觉系统的操纵是否会改变 AD
为此,我们采用了一种基于细胞周期的新型散发性 AD 模型。
失调——这种现象在 AD 患者的大脑标本中常见。
因此,这些 AD 模型小鼠的直接处理基因不携带特定突变。
然而,β 淀粉样蛋白或 tau 淀粉样蛋白已被证明表现出特征性斑块和
缠结,类似于 AD 大脑中所见的情况,以及神经变性,这在大多数情况下都不会出现
散发性 AD 的其他小鼠模型 将使用的家族性 AD 模型是 APP/PS1。
小鼠,因为它已被证明表现出中枢听觉功能障碍并且具有时间过程
在目标 1 中,我们将测试外周和 AD 模型的病理学。
这些小鼠的中枢听觉功能,就像 AD 患者一样,它们会有更多
与外周听觉功能相比,中枢听觉功能受损 在目标 2 中,我们将诱发听力。
损失和检查 AD 病理学检查和进展的诱导
使用连续 FDG PET 成像和行为学相结合的神经退行性表型
我们追求听力损失会恶化 AD 病理学和探索性分析。
将确定中枢听觉的变化是否比非听觉的变化更严重
这项工作的成功完成将首次决定该地区的性质。
听力损失与 AD 病理之间的关联 如果发现因果关系,未来的工作。
将确定这种关联的分子机制以及 ARHL 的缓解是否也有效
鉴于 ARHL(听觉)干预措施的成功进展,减少了 AD 病理学。
康复、“智能”助听器、人工耳蜗等),这项研究可以奠定
为 ARHL 早期干预以减轻痴呆症负担奠定基础。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Super-Resolution Ultrasound Reveals Cerebrovascular Impairment in a Mouse Model of Alzheimer's Disease.
超分辨率超声揭示阿尔茨海默病小鼠模型中的脑血管损伤。
- DOI:
- 发表时间:2024-02-28
- 期刊:
- 影响因子:0
- 作者:Lowerison, Matthew R;Vaithiyalingam Chandra Sekaran, Nathiya;Dong, Zhijie;Chen, Xi;You, Qi;Llano, Daniel A;Song, Pengfei
- 通讯作者:Song, Pengfei
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL A LLANO其他文献
DANIEL A LLANO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL A LLANO', 18)}}的其他基金
Super-resolution imaging of brain microvascular changes in a model of Alzheimer Disease
阿尔茨海默病模型脑微血管变化的超分辨率成像
- 批准号:
10430929 - 财政年份:2022
- 资助金额:
$ 24.16万 - 项目类别:
Synaptic mechanisms of auditory thalamic cross-modal communication
听觉丘脑跨模式通讯的突触机制
- 批准号:
10540232 - 财政年份:2021
- 资助金额:
$ 24.16万 - 项目类别:
Examination of the bidirectional relationship between hearing loss and Alzheimer Disease pathology
听力损失与阿尔茨海默病病理学之间双向关系的检查
- 批准号:
10196576 - 财政年份:2021
- 资助金额:
$ 24.16万 - 项目类别:
Synaptic mechanisms of auditory thalamic cross-modal communication
听觉丘脑跨模式通讯的突触机制
- 批准号:
10320450 - 财政年份:2021
- 资助金额:
$ 24.16万 - 项目类别:
An upright multiphoton microscope for biomedical research applications
用于生物医学研究应用的正置多光子显微镜
- 批准号:
9274589 - 财政年份:2017
- 资助金额:
$ 24.16万 - 项目类别:
Functional organization of the auditory corticocollicular system
听觉皮质皮质系统的功能组织
- 批准号:
8888751 - 财政年份:2015
- 资助金额:
$ 24.16万 - 项目类别:
Functional organization of the auditory corticocollicular system
听觉皮质皮质系统的功能组织
- 批准号:
9020945 - 财政年份:2015
- 资助金额:
$ 24.16万 - 项目类别:
Functional organization of the auditory corticocollicular system
听觉皮质皮质系统的功能组织
- 批准号:
10584167 - 财政年份:2015
- 资助金额:
$ 24.16万 - 项目类别:
Thalamic reticular nucleus modulation of auditory thalamocortical function
丘脑网状核对听觉丘脑皮质功能的调节
- 批准号:
8951649 - 财政年份:2015
- 资助金额:
$ 24.16万 - 项目类别:
Thalamic reticular nucleus modulation of auditory thalamocortical function
丘脑网状核对听觉丘脑皮质功能的调节
- 批准号:
9096739 - 财政年份:2015
- 资助金额:
$ 24.16万 - 项目类别:
相似国自然基金
面向电力储能集群系统的加速退化试验与寿命评估方法研究
- 批准号:62303293
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向计算密集型应用的新型计算范式及其加速器关键技术
- 批准号:62374108
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于任意精度计算架构的量子信息处理算法硬件加速技术研究
- 批准号:62304037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分布式非凸非光滑优化问题的凸松弛及高低阶加速算法研究
- 批准号:12371308
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
极端光场条件下正电子束的产生、加速和操控研究
- 批准号:12375244
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
COVID-19 related inflammation as a risk factor for age-related cognitive decline and Alzheimer's Disease
COVID-19 相关炎症是与年龄相关的认知能力下降和阿尔茨海默病的危险因素
- 批准号:
10646590 - 财政年份:2023
- 资助金额:
$ 24.16万 - 项目类别:
Epigenetic Regulation in Aging and Alzheimer's Disease
衰老和阿尔茨海默病的表观遗传调控
- 批准号:
10564831 - 财政年份:2022
- 资助金额:
$ 24.16万 - 项目类别:
Examination of the bidirectional relationship between hearing loss and Alzheimer Disease pathology
听力损失与阿尔茨海默病病理学之间双向关系的检查
- 批准号:
10196576 - 财政年份:2021
- 资助金额:
$ 24.16万 - 项目类别:
Role of Adaptive Myelination in Auditory Brain Plasticity
适应性髓鞘形成在听觉脑可塑性中的作用
- 批准号:
10713730 - 财政年份:2021
- 资助金额:
$ 24.16万 - 项目类别:
NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease
NPTX2:在正常衰老和阿尔茨海默病中保护记忆回路
- 批准号:
10621736 - 财政年份:2021
- 资助金额:
$ 24.16万 - 项目类别: